Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    MA02 - Molecular Underpinnings of Lung Cancer Histological Differentiation and Targeted Therapeutics

    • 10:45 - 11:45
    • 8/07/2022
    • Location: Hall C8
    • Not for CME Credit
    • Type: Mini Oral
    • Track: Tumor Biology and Biomarkers
    • +

      MA02.04 - Molecular Drivers and Therapeutic Targets for Neuroendocrine Transformation in Lung Cancer

      10:52 - 10:57  |  Presenter: Triparna Sen

      • Abstract

      Loading...

  • +

    ES07 - Impact of Tumor Plasticity and Molecular/Immune Adaptations in Treatment Sensitivity and Resistance

    • 12:00 - 13:00
    • 8/07/2022
    • Location: Strauss 1/2
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Tumor Biology and Biomarkers
    • +

      ES07.05 - Tumor Cell Plasticity and Histological/Molecular Changes: Focus On Transition from NSCLC to SCLC

      12:26 - 12:38  |  Presenter: Triparna Sen

      • Abstract

      Loading...

  • +

    OA04 - Mesothelioma Under the Looking Glass

    • 14:30 - 15:30
    • 8/07/2022
    • Location: Hall C8
    • Not for CME Credit
    • Type: Oral
    • Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies
    • +

      OA04.03 - Multi-omic Analysis of Malignant Pleural Mesothelioma PDXs Reveal Pathway Alterations and Therapeutic Targets

      14:32 - 14:42  |  Presenter: Triparna Sen

      • Abstract

      Loading...

  • +

    EP16.03 - Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics
    • +

      EP16.03-030 - AKT Inhibition as a Therapeutic Strategy to Constrain Histological Transdifferentiation in EGFR-mutant Lung Adenocarcinoma.

      Presenter: Alvaro Quintanal-Villalonga

      • Abstract

      Loading...